These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 19274984

  • 21. [Leprosy, a neurologic disease].
    Coeytaux A, Truffert A, Mueller Y, Antille C, Jackson Y.
    Rev Med Suisse; 2007 May 09; 3(110):1178, 1180-4. PubMed ID: 17564345
    [Abstract] [Full Text] [Related]

  • 22. Challenges presented by nerve damage in leprosy.
    Harboe M, Aseffa A, Leekassa R.
    Lepr Rev; 2005 Mar 09; 76(1):5-13. PubMed ID: 15881032
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Leprous neuropathy.
    de Freitas MR, Said G.
    Handb Clin Neurol; 2013 Mar 09; 115():499-514. PubMed ID: 23931798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of the change in clinical severity scale score and a retrospective physician assessment of neurological outcome in individuals with leprosy associated nerve function impairment after treatment with corticosteroids.
    Walker SL, Nicholls PG, Dhakal S, Hawksworth RA, Macdonald M, Mahat K, Ruchal S, Hamal S, Hagge DA, Neupane KD, Lockwood DN.
    Lepr Rev; 2012 Jun 09; 83(2):154-63. PubMed ID: 22997691
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal.
    Marlowe SN, Hawksworth RA, Butlin CR, Nicholls PG, Lockwood DN.
    Trans R Soc Trop Med Hyg; 2004 Oct 09; 98(10):602-9. PubMed ID: 15289097
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Some immunological aspects in the reaccional states of Hansen disease].
    Rada E, Nacarid A, Convit J.
    Invest Clin; 2005 Dec 09; 46(4):381-9. PubMed ID: 16353545
    [Abstract] [Full Text] [Related]

  • 36. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
    Khambati FA, Shetty VP, Ghate SD, Capadia GD, Pai VV, Ganapati R.
    Lepr Rev; 2008 Jun 09; 79(2):134-53. PubMed ID: 18711936
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Leprous neuropathies.
    Waters MF, Jacobs JM.
    Baillieres Clin Neurol; 1996 Mar 09; 5(1):171-97. PubMed ID: 8732207
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.
    Wagenaar I, Post E, Brandsma W, Bowers B, Alam K, Shetty V, Pai V, Husain S, Sigit Prakoeswa CR, Astari L, Hagge D, Shah M, Neupane K, Tamang KB, TENLEP study group, Nicholls P, Richardus JH.
    PLoS Negl Trop Dis; 2017 Oct 09; 11(10):e0005952. PubMed ID: 28976976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.